KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Chemed (CHE) Short term Debt (2016 - 2023)

Chemed filings provide 8 years of Short term Debt readings, the most recent being $5.0 million for Q1 2023.

For the quarter ending Q1 2023, Short term Debt changed N/A year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Mar 2023, changed N/A, and an annual FY2022 reading of $5.0 million, changed N/A over the prior year.
Short term Debt hit $5.0 million in Q1 2023 for Chemed, roughly flat from $5.0 million in the prior quarter.
The five-year high for Short term Debt was $5.0 million in Q2 2022, with the low at $5.0 million in Q2 2022.